Physician profile
John H Johnson
NPI 1841581790
$848.08
in general payments reported to CMS, 2019-2025
15 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.81 · 2020: $32.93 · 2021: $81.80 · 2022: $17.32 · 2023: $124 · 2024: $73.26 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $188.59 | 2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Tarsus Pharmaceuticals, INC. | $166.40 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $89.60 | 2020-2025 | Clareon, Argos |
| Allergan, INC. | $70.77 | 2019-2022 | |
| Dompe US, INC. | $67.22 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $43.52 | 2021-2023 | |
| Kala Pharmaceuticals, INC. | $43.50 | 2021 | |
| Bausch & Lomb Americas INC. | $32.93 | 2023-2025 | Envista Aspire Iol, Infuse |
| Carl Zeiss Meditec USA, INC. | $26.65 | 2025 | Iolmaster 700 |
| Rxsight INC | $25.15 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Ocular Therapeutix, INC. | $22.88 | 2024 | Dextenza |
| Horizon Therapeutics Plc | $21.90 | 2023 | Tepezza |
| Regeneron Healthcare Solutions, INC. | $19.21 | 2023 | Eylea Hd |
| Ani Pharmaceuticals, INC. | $17.11 | 2023 | Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.